Chemical Structure (Gabapenin 01)
Gabapentin Tablet, Coated
Product Images NDC 50090-7269
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapenin 02)
Figure 2 (Gabapenin 03)
This table shows the Mean Pain Score over a study period that includes a 3-week dose titration period followed by a 4-week fixed dose period. The study compares the effects of a placebo, 1,800 mg/day of Gabapentin, and 2,400 mg/day of Gabapentin on pain scores. The baseline and subsequent time points are labeled from 1 to 6 to track changes in pain scores.*
Figure 3 (Gabapenin 04)
This is a breakdown of percentages ranging from 0% to 100% with indication of statistical significance levels. The text also mentions two studies with results showing percentages of 20% and 32% in Study 1, and 34% in Study 2. There seems to be some missing information or formatting issues present.*
Figure 4 (Gabapenin 05)
Label Image (Lbl500907269)
The text provides product information for 600mg SharsenTIN tablets. The product code is No. 58956-0 and there are 90 tablets in total. The tablets should be stored at 77 degrees Fahrenheit.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
